Risk Summary There are either no or only limited data on the presence of insulin glargine in human milk, the effects on breastfed infant, or the effects on milk production
10.1016/s0928-4257(97)89478-8 6 HuangT.ZhangK.SunL.XueX.ZhangC.ShuZ.et al (2015)
Separate and combined gluco-metabolic effects of endogenous glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in healthy individuals
Dietary factors that could enhance peptide outcomes include a Mediterranean-style diet, balanced protein distribution at every meal, low-carbohydrate levels that dont cause large insulin spikes, and anti-inflammatory selections that reduce oxidative stress
Choose Your Salsa Carefully Salsas are your flavor heroes here, and theyre all pretty low in calories
CrossRef Development of a risk prediction model for gastrointestinal adverse events associated with semaglutide administration in patients with type 2 diabetes mellitus Deyong Yue, Xuesheng Hua, Ling Zhu, Jun Wang, Lihua Gu, Zhengxia Yuan, Wenle Jian, Yirong Chen, Guoliang Meng Frontiers in Endocrinology.2025;[Epub] CrossRef Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist Therapy: The Emerging Role of Oral Agents Sherry Yun Wang, Ryan Stofer, Hao Wang, Gregory A